Bio-Rad Laboratories
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $651,600 | $585,400 | $667,475 | $649,729 |
Gross Profit | 345,400 | 306,000 | 341,912 | 355,903 |
EBITDA | 477,200 | 133,500 | -847,400 | 922,894 |
EBIT | 426,600 | 95,400 | -896,700 | 873,794 |
Net Income | 317,800 | 64,000 | -715,800 | 653,172 |
Net Change In Cash | 651,600 | 585,400 | 667,475 | 649,729 |
Free Cash Flow | 70,800 | 95,500 | 81,248 | 99,971 |
Cash | 369,300 | 521,400 | 488,100 | 410,377 |
Basic Shares | 27,228 | 27,955 | 27,997 | 27,985 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,566,500 | $2,671,262 | $2,802,249 | $2,922,545 |
Gross Profit | 1,378,900 | 1,426,946 | 1,567,330 | 1,638,096 |
EBITDA | -2,142,000 | -654,800 | -4,488,959 | 5,588,206 |
EBIT | -2,293,600 | -800,700 | -4,666,159 | 5,450,606 |
Net Income | -1,844,200 | -637,324 | -3,627,535 | 4,254,257 |
Net Change In Cash | 2,566,500 | 2,671,262 | 2,802,249 | 2,922,545 |
Cost of Revenue | -39,570 | -195,982 | ||
Free Cash Flow | 266,200 | 218,263 | 80,290 | 535,718 |
Cash | 488,100 | 403,800 | 434,215 | 470,783 |
Basic Shares | 28,214 | 29,209 | 29,785 | 30,208 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $2.61 |
2025-03-31 | $2.54 |
2024-12-31 | $2.90 |
